Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 30;18(5):2082206.
doi: 10.1080/21645515.2022.2082206. Epub 2022 Jun 14.

Acute encephalitis after COVID-19 vaccination: A case report and literature review

Affiliations
Review

Acute encephalitis after COVID-19 vaccination: A case report and literature review

Jhih-Jian Gao et al. Hum Vaccin Immunother. .

Abstract

Vaccine-related immune responses are one of the causes of encephalitis. Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) have been administered worldwide due to the ongoing global pandemic; cases of SARS-CoV-2 vaccination-related encephalitis were scarcely reported. An 82-year-old female was diagnosed with acute encephalitis following her first dose of vaccination with mRNA-1273 against SARS-CoV-2. The patient presented with fever and headache five days after vaccination, followed by behavior change 17 days after vaccination. Electroencephalographic recordings revealed focal slow waves in the right frontoparietal regions. Brain MRI revealed the signal change in the right middle and posterior temporal lobe. Cerebrospinal fluid analysis showed mildly elevated protein. She responded well to steroid pulse therapy and made a full recovery. The severity of the immune response following COVID-19 vaccination may be alleviated if adequate treatment is achieved. Physicians must be alert for encephalitis after vaccination to help ensure a favorable outcome.

Keywords: COVID-19; SARS-COV-2; encephalitis; neurological complications; vaccination.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Summarizes the timeline of clinical course and manifestations of the patient with post-vaccination encephalitis.
Figure 2.
Figure 2.
Post-COVID-19 vaccination encephalitis: magnetic resonance imaging (MRI) of the brain demonstrates prominent T2 fluid attenuated inversion recovery (FLAIR)-hyperintense lesions in the right middle temporal (a) and posterior temporal (c) regions with gadolinium enhancement (b, d). The EEG recordings exhibit intermittent focal slow waves in the right frontocentral to parietal regions (e). Post-treatment brain MRI (at 20 days after admission) shows attenuated signal intensity on the T2 FLAIR image (f, h), in the absence of enhancement in the middle-posterior temporal gyri (g, i). EEG findings were normal (j).

References

    1. Halperin JJ. Diagnosis and management of acute encephalitis. Handb Clin Neurol. 2017;140:1–7. doi:10.1016/B978-0-444-63600-3.00018-0. - DOI - PubMed
    1. George BP, Schneider EB, Venkatesan A. Encephalitis hospitalization rates and inpatient mortality in the United States, 2000–2010. Plos One. 2014;9(9):e104169. doi:10.1371/journal.pone.0104169. - DOI - PMC - PubMed
    1. Vandervorst F, Guldolf K, Peeters I, Vanderhasselt T, Michiels K, Berends KJ, Van Laethem J, Pipeleers L, Vincken S, Seynaeve L, et al. Encephalitis associated with the SARS-CoV-2 virus: a case report. Interdiscip Neurosurg. 2020;22:100821. doi:10.1016/j.inat.2020.100821. - DOI - PMC - PubMed
    1. Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, Ueno M, Sakata H, Kondo K, Myose N, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55–58. doi:10.1016/j.ijid.2020.03.062. - DOI - PMC - PubMed
    1. Manzano GS, McEntire CRS, Martinez-Lage M, Mateen FJ, Hutto SK. Acute disseminated encephalomyelitis and acute hemorrhagic leukoencephalitis following COVID-19: systematic review and meta-synthesis. Neurol Neuroimmunol Neuroinflamm. 2021;8(6):e1080. doi:10.1212/NXI.0000000000001080. - DOI - PMC - PubMed

Substances